Skip to main content

Thermo Fisher Scientific Specialty Diagnostics revenue

  • TMO · NYSE
  • Instruments
  • Life Sciences Tools & Services
  • S&P 500
$700.22+0.11%Close 13 Nov 2026

Specialty Diagnostics revenue at Thermo Fisher Scientific came to $1.1B for the quarter to 26 Sep 2026, down 6.5% from a year earlier.

As Thermo Fisher Scientific reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 30 Oct 2026.

By quarter

$1.1BDec 2023$1.1BMar 2024$1.1BJun 2024$1.1BSep 2024$1.2BDec 2024$1.1BMar 2025$1.1BJun 2025$1.2BSep 2025$1.2BDec 2025$1.1BMar 2026$1.2BJun 2026$1.1BSep 2026
Thermo Fisher Scientific Specialty Diagnostics revenue, every reported period
Period endingSpecialty Diagnostics revenueChange on a yearFiled
26 Sep 2026$1.1Bdown 6.5%30 Oct 2026
27 Jun 2026$1.2Bup 6.3%31 Jul 2026
28 Mar 2026$1.1Bdown 0.5%1 May 2026
31 Dec 2025$1.2Bup 5.4%26 Feb 2026
27 Sep 2025$1.2Bup 4.0%31 Oct 2025
28 Jun 2025$1.1Bup 1.5%1 Aug 2025
29 Mar 2025$1.1Bup 3.5%2 May 2025
31 Dec 2024$1.2Bup 4.7%20 Feb 2025
28 Sep 2024$1.1Bup 4.2%1 Nov 2024
29 Jun 2024$1.1Bup 0.7%2 Aug 2024
30 Mar 2024$1.1Bup 0.1%3 May 2024
31 Dec 2023$1.1Bdown 0.9%22 Feb 2024
30 Sep 2023$1.1Bup 1.7%3 Nov 2023
1 Jul 2023$1.1Bup 0.7%4 Aug 2023
1 Apr 2023$1.1Bdown 25.2%5 May 2023
31 Dec 2022$1.1Bdown 22.9%23 Feb 2023
1 Oct 2022$1.1Bdown 21.8%4 Nov 2022
2 Jul 2022$1.1Bdown 10.9%5 Aug 2022
2 Apr 2022$1.5Bdown 8.2%6 May 2022
31 Dec 2021$1.4Bdown 26.4%24 Feb 2022
2 Oct 2021$1.4Bdown 4.8%4 Nov 2021
3 Jul 2021$1.2Bup 25.0%6 Aug 2021
3 Apr 2021$1.6Bup 68.6%7 May 2021
31 Dec 2020$2.0Bup 109.5%25 Feb 2021
26 Sep 2020$1.4Bup 62.7%30 Oct 2020
27 Jun 2020$988.0Mup 4.8%31 Jul 2020
28 Mar 2020$958.0Mup 0.1%1 May 2020
31 Dec 2019$939.0Mdown 1.3%26 Feb 2020
28 Sep 2019$879.0Mdown 1.7%1 Nov 2019
29 Jun 2019$943.0Mup 1.2%2 Aug 2019
30 Mar 2019$957.0Mup 1.1%3 May 2019
31 Dec 2018$951.0M—27 Feb 2019
29 Sep 2018$894.0Mup 5.9%2 Nov 2018
30 Jun 2018$932.0Mup 8.1%3 Aug 2018
31 Mar 2018$947.0M—4 May 2018
30 Sep 2017$844.0M—3 Nov 2017
1 Jul 2017$862.0M—4 Aug 2017
30 Mar 2013$805.6Mup 10.1%3 May 2013
31 Dec 2012$791.8Mup 12.1%27 Feb 2013
29 Sep 2012$706.7Mup 14.8%2 Nov 2012

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Thermo Fisher Scientific: Organic revenue (change on a year) · Remaining performance obligations · Product revenues · Service revenues · Consumables revenue · Instruments revenue · Clinical research revenue · Research and safety market channel revenue · Pharma services revenue · Biosciences revenue · BioProduction revenue · Chromatography and mass spectrometry revenue · Electron microscopy revenue · Genetic sciences revenue · Laboratory products revenue · Healthcare market channel revenue · Chemical analysis revenue · Clinical diagnostics revenue · ImmunoDiagnostics revenue · Transplant diagnostics revenue · Microbiology revenue · Laboratory Products and Biopharma Services revenue · Life Sciences Solutions revenue · Analytical Instruments revenue · financial statements

Every KPI and segment of TMO, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.